Your session is about to expire
← Back to Search
PrEP Talk for HIV Prevention in Young Black MSM (PrEP-Talk Trial)
Phase < 1
Recruiting
Research Sponsored by California State University, Dominguez Hills
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Currently using PrEP: Index must be not currently using PrEP; Close Friend:none
Currently using PrEP: Index must be not currently using PrEP
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
PrEP-Talk Trial Summary
This trial aims to increase PrEP uptake and adherence among young, black men who have sex with men. This will be done through qualitative formative research, partnering with a community advisory board, and field tests of the intervention with 5 YBMSM and CF dyads.
Who is the study for?
This trial is for Black or multiracial males aged 18-29 who identify as gay, bisexual, gender queer/non-binary/gender non-conforming. They must be HIV negative and not currently using PrEP. Participants need a close friend willing to support their sexual health goals for HIV prevention.Check my eligibility
What is being tested?
'PrEP-Talk' is an intervention being tested to increase the uptake and adherence of PrEP among young Black men who have sex with men (YBMSM). It involves counseling from a PrEP Counselor and support from a close friend, assessed through focus groups and a pilot randomized controlled trial.See study design
What are the potential side effects?
Concerns about side effects are part of what 'PrEP-Talk' aims to address; however, common side effects of taking PrEP can include nausea, headache, stomach pain, weight loss but these vary by individual.
PrEP-Talk Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am not currently using PrEP.
Select...
I am not currently using PrEP.
PrEP-Talk Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Decision to Begin PrEP
PrEP-Talk Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants will take part in the PrEP Talk intervention sessions.
Group II: ControlActive Control1 Intervention
Participants will receive standard care.
Find a Location
Who is running the clinical trial?
California State University, Dominguez HillsLead Sponsor
4 Previous Clinical Trials
235 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I regularly discuss important topics like sexual health with a close friend.If you identify as Black/African American or multiracial with Black/African American ancestry, you can participate. There are no restrictions for the racial/ethnic background of your close friend.You identify yourself as gay or bisexual and have no close friends.I am not currently using PrEP.I am not currently using PrEP.I am male, gender queer, non-binary, or gender non-conforming.I am male, gender queer, non-binary, or gender non-conforming.My close friend is Black, gay or bisexual, and aged 18-29.My close friend is a Black gay or bisexual man aged 18-29.I am between 18 and 29 years old.My close friend is supportive of my sexual health goals for HIV prevention.You do not have a friend with whom you regularly discuss important topics like sexual health.My close friend is supportive of my sexual health goals for HIV prevention.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are elderly individuals beyond the age of 80 eligible for this experimental research?
"Adolescents between the ages of 18 and 29 are suitable for enrollment in this trial."
Answered by AI
How many participants are being accepted into the research endeavor?
"Affirmative. Data hosted on clinicaltrials.gov reveals that this research project, first launched on September 1st 2020, is still recruiting participants. Approximately 120 individuals need to be recruited from a single medical centre."
Answered by AI
What type of participants are best suited for inclusion in this experiment?
"To be considered for inclusion in this trial, applicants must have rc-prep and lie within the accepted age range of 18 to 29 years old. The study is looking for a total of 120 participants."
Answered by AI
Is recruitment for this experiment ongoing?
"Yes, clinicaltrials.gov indicates that this trial is active and recruiting patients. This study was initially published on the 1st of September 2020 with a most recent edit made on July 26th 2022; it requires 120 participants at only one location."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger